|
|
|
Volumn 324, Issue 7342, 2002, Pages 886-890
|
|
Selling sickness: The pharmaceutical industry and disease mongering
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALOSETRON;
ANTIDEPRESSANT AGENT;
FINASTERIDE;
MOCLOBEMIDE;
SILDENAFIL;
CONSUMER;
DRUG INDUSTRY;
DRUG MARKETING;
ERECTILE DYSFUNCTION;
HAIR LOSS;
HUMAN;
IRRITABLE COLON;
MEDICAL EDUCATION;
OSTEOPOROSIS;
PREVALENCE;
PRIORITY JOURNAL;
PUBLIC OPINION;
REVIEW;
SOCIAL PHOBIA;
ALOPECIA;
COLONIC DISEASES, FUNCTIONAL;
DISEASE;
DRUG INDUSTRY;
DRUG THERAPY;
FEMALE;
HUMANS;
IMPOTENCE;
MALE;
OSTEOPOROSIS, POSTMENOPAUSAL;
PATIENT ACCEPTANCE OF HEALTH CARE;
PREVENTIVE MEDICINE;
RISK FACTORS;
|
|
EID: 0037070782
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (734)
|
|
References (24)
|
